310 reports of this reaction
1.8% of all TIMOLOL MALEATE reports
#12 most reported adverse reaction
INTRAOCULAR PRESSURE INCREASED is the #12 most commonly reported adverse reaction for TIMOLOL MALEATE, manufactured by Bausch & Lomb Incorporated. There are 310 FDA adverse event reports linking TIMOLOL MALEATE to INTRAOCULAR PRESSURE INCREASED. This represents approximately 1.8% of all 16,822 adverse event reports for this drug.
Patients taking TIMOLOL MALEATE who experience intraocular pressure increased should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
INTRAOCULAR PRESSURE INCREASED is a less commonly reported adverse event for TIMOLOL MALEATE, but still significant enough to appear in the safety profile.
In addition to intraocular pressure increased, the following adverse reactions have been reported for TIMOLOL MALEATE:
The following drugs have also been linked to intraocular pressure increased in FDA adverse event reports:
INTRAOCULAR PRESSURE INCREASED has been reported as an adverse event in 310 FDA reports for TIMOLOL MALEATE. This does not prove causation, but indicates an association observed in post-market surveillance data.
INTRAOCULAR PRESSURE INCREASED accounts for approximately 1.8% of all adverse event reports for TIMOLOL MALEATE, making it a notable side effect.
If you experience intraocular pressure increased while taking TIMOLOL MALEATE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.